drugset / Trial / NCT00672568

Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder

NCT00672568 ↗

Phase 2 Terminated 24 enrolled Anesiva, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety, tolerability and explore the efficacy of a single intraoperative injection of 4975 in patients undergoing arthroscopic surgery for rotator cuff repair of the shoulder

Timeline

Start
2008-07
Primary completion
2008-10
Completion
2008-12

Outcome

Outcome not reported

Stopped (Enrollment): “Study has been halted after completing Stage 1, for corporate reasons. No future patients will be enrolled or treated.”

Drugs

EvaluationDrugModalityDoseRoute
Subject 4975 Unknown 0.1 mg Other
Subject 4975 Unknown 0.5 mg Other
Subject 4975 Unknown 0.75 mg Other

Indications